Head-to-head comparison
Andrew Meds vs Hims & Hers
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Andrew Meds prices both molecules openly and says which 44 states can be treated by questionnaire alone — then routes every Get Started button on its semaglutide page to a different, cheaper program.
From $199/mo sema · From $299/mo tirz · Verified September 2026
Marked down on: Every Get Started button on the compounded semaglutide page opens a microdosing program at $99 a month, and that word appears nowhere else on the site.
Desk Score
Mass-market app-first program with nationwide polish — tirzepatide pricing disclosure lags the ranking.
$199/mo sema
Marked down on: Tirzepatide pricing inconsistently disclosed
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Andrew Meds and Hims & Hers land level on the Desk Score at 79/100 — too close to call. The right choice comes down to which trade-offs fit your situation.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Andrew Meds
79/100
C+
Hims & Hers
79/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Andrew Meds | Hims & Hers |
|---|---|---|
| Semaglutide | From $199/moFrom $199/mo (compounded) | $199/mo$199/mo |
| Tirzepatide | From $299/moFrom $299/mo (compounded) | Not listed on Hims & Hers's site |
| Coverage | All 50 states and D.C. (44 by questionnaire, the rest by live visit) | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Anyone who will confirm which program the checkout actually opened before paying for it. | People who want a familiar consumer-brand app experience and don't need tirzepatide. |
| Desk Score | 79/100C+ | 79/100C+ |
The verdict
Too close to callAndrew Meds and Hims & Hers land level on the Desk Score at 79/100 — too close to call. The right choice comes down to which trade-offs fit your situation.
Choose Andrew Meds if…
Anyone who will confirm which program the checkout actually opened before paying for it.
From $199/mo sema · From $299/mo tirz · All 50 states and D.C. (44 by questionnaire, the rest by live visit)
Choose Hims & Hers if…
People who want a familiar consumer-brand app experience and don't need tirzepatide.
$199/mo sema · All 50 states
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Andrew Meds · Hims & Hers.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- Andrew Meds vs CoreAge Rx
- CoreAge Rx vs Hims & Hers
- Andrew Meds vs HealthRX
- Hims & Hers vs Ondra Health
- Andrew Meds vs Breeze Meds
- Hims & Hers vs Vaylen
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.